The Latest Options and Future Agents for Treating Male Hypogonadism

November 2007 in “ Expert Opinion on Pharmacotherapy ”

Daniel L. Edelstein, Mala S. Sivanandy, Sadeka Shahani, Shehzad Basaria

testosterone replacement therapy TRT testosterone gels testosterone patches testosterone injections hypogonadism pharmacological agents testosterone therapy testosterone gel testosterone patch testosterone shot

Studysummary This review discusses developments in testosterone therapy, including the shift towards transdermal therapies and long-acting injectables, but reports no new clinical findings; emerging therapies are in development.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document reviewed the latest treatment options and potential future agents for male hypogonadism as of 2007. It discussed various therapies, including testosterone replacement therapy (TRT) in different forms such as gels, patches, and injections. The review also highlighted the importance of individualized treatment plans based on patient-specific factors and the need for ongoing monitoring to manage potential side effects. Additionally, the authors explored emerging treatments and the potential for new pharmacological agents that could offer more targeted and effective management of hypogonadism in the future.

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations

280 citations , May 2005 in “Andrology”

This document outlines recommendations from an international panel on testosterone therapy for aging men with late-onset hypogonadism, emphasizing the need for careful assessment and monitoring due to limited long-term safety data.

research Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor Modulators

129 citations , January 2004 in “Journal of medicinal chemistry”

This study synthesized nonsteroidal ligands as second-generation androgen receptor agonists and identified three compounds with significant anabolic activity and moderate to minimal androgenic activity in vivo.

research The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double-Blind Study

110 citations , April 2002 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception

research Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception

14 citations , December 1998 in “The Journal of Clinical Endocrinology and Metabolism”

This study found that MENT is 10 times more potent than testosterone in suppressing gonadotropins and contributing to anabolism in monkeys, with a potentially wider therapeutic index for human androgen replacement and male contraception.